| Anti-tubercular agents. Part 8: Synthesis, antibacterial and antitubercular activity of 5-nitrofuran based 1, 2, 3-triazoles A Kamal, SMA Hussaini, S Faazil, Y Poornachandra, GN Reddy, ... Bioorganic & medicinal chemistry letters 23 (24), 6842-6846, 2013 | 53 | 2013 |
| UDP-GlcNAc pathway: Potential target for inhibitor discovery against M. tuberculosis C Rani, IA Khan European Journal of Pharmaceutical Sciences 83, 62-70, 2016 | 37 | 2016 |
| Structure-based virtual screening and biochemical validation to discover a potential inhibitor of the SARS-CoV-2 main protease A Gupta, C Rani, P Pant, V Vijayan, N Vikram, P Kaur, TP Singh, ... ACS omega 5 (51), 33151-33161, 2020 | 36 | 2020 |
| High-throughput screen identifies small molecule inhibitors targeting acetyltransferase activity of Mycobacterium tuberculosis GlmU C Rani, R Mehra, R Sharma, R Chib, P Wazir, A Nargotra, IA Khan Tuberculosis 95 (6), 664-677, 2015 | 36 | 2015 |
| Computationally Guided Identification of Novel Mycobacterium tuberculosis GlmU Inhibitory Leads, Their Optimization, and in Vitro Validation R Mehra, C Rani, P Mahajan, RA Vishwakarma, IA Khan, A Nargotra ACS combinatorial science 18 (2), 100-116, 2016 | 34 | 2016 |
| Escherichia coli N-acetylglucosamine-1-phosphate-uridyltransferase/glucosamine-1-phosphate-acetyltransferase (GlmU) inhibitory activity of terreic acid isolated from … R Sharma, MR Lambu, U Jamwal, C Rani, R Chib, P Wazir, D Mukherjee, ... Journal of biomolecular screening 21 (4), 342-353, 2016 | 26 | 2016 |
| Identification and characterization of novel small molecule inhibitors of the acetyltransferase activity of Escherichia coli N-acetylglucosamine-1-phosphate … R Sharma, C Rani, R Mehra, A Nargotra, R Chib, VS Rajput, S Kumar, ... Applied microbiology and biotechnology 100, 3071-3085, 2016 | 16 | 2016 |
| BA. 1, BA. 2 and BA. 2.75 variants show comparable replication kinetics, reduced impact on epithelial barrier and elicit cross-neutralizing antibodies J Singh, A Anantharaj, A Panwar, C Rani, M Bhardwaj, P Kumar, ... PLoS Pathogens 19 (2), e1011196, 2023 | 11 | 2023 |
| Synthesis and biological evaluation of substituted N-alkylphenyl-3, 5-dinitrobenzamide analogs as anti-TB agents G Munagala, KR Yempalla, SK Aithagani, NP Kalia, F Ali, I Ali, VS Rajput, ... Medchemcomm 5 (4), 521-527, 2014 | 11 | 2014 |
| Structure of yak lactoperoxidase at 1.55 Å resolution V Viswanathan, C Rani, N Ahmad, PK Singh, P Sharma, P Kaur, ... The Protein Journal 40, 8-18, 2021 | 6 | 2021 |
| Climate Change and Zoonotic Diseases: Malaria, Plague, Dengue, and Encephalitis RK Pandey, AK Dubey, S Sharma, C Rani Emerging Pandemics, 81-98, 2023 | 3 | 2023 |
| Ba. 1 and BA. 2 sub-lineages of Omicron variant have comparable replication kinetics and susceptibility to neutralization by antibodies J Singh, A Panwar, A Anantharaj, C Rani, M Bhardwaj, P Kumar, K Pargai, ... MedRxiv, 2022.01. 28.22269990, 2022 | 3 | 2022 |
| Infection with Omicron variant generates neutralizing antibodies to BA. 1 and BA. 2 sub-lineages and induces higher levels of cross-neutralizing antibodies to Delta variant. J Singh, A Panwar, A Anantharaj, C Rani, M Bhardwaj, P Kumar medRxiv, 2022, 2022 | 3 | 2022 |
| Potassium-induced partial inhibition of lactoperoxidase: Structure of the complex of lactoperoxidase with potassium ion at 2.20 Å resolution PK Singh, S Pandey, C Rani, N Ahmad, V Viswanathan, P Sharma, ... JBIC Journal of Biological Inorganic Chemistry 26, 149-159, 2021 | 3 | 2021 |
| Tuberculosis: An Old Enemy of Mankind and Possible Next Pandemic C Rani, RK Pandey, S Ubaid-Ullah Emerging Pandemics, 47-62, 2023 | 2 | 2023 |
| Biophysical characterization of type III pantothenate kinase (PanK) from acinetobacter baumannii A Singla, P Sharma, A Gupta, N Iqbal, C Rani, TP Singh, S Sharma Protein and Peptide Letters 28 (4), 450-458, 2021 | 2 | 2021 |
| Hybrid immunity from SARS-CoV-2 delta variant surge induced low to undetectable levels of neutralizing antibodies against Omicron variant J Singh, A Panwar, A Anantharaj, C Rani, M Bhardwaj, P Kumar, K Pargai, ... | | 2022 |
